# GORE® Septal Occluder Device for Patent Foramen Ovale (PFO) Closure in Stroke Patients

> **NCT00738894** · NA · COMPLETED · sponsor: **W.L.Gore & Associates** · enrollment: 664 (actual)

## Conditions studied

- Stroke
- Transient Ischemic Attack

## Interventions

- **DEVICE:** Septal Occluder Device
- **DRUG:** Antiplatelet Medical Therapy

## Key facts

- **NCT ID:** NCT00738894
- **Lead sponsor:** W.L.Gore & Associates
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12-10
- **Primary completion:** 2017-04-24
- **Final completion:** 2020-05-11
- **Target enrollment:** 664 (ACTUAL)
- **Last updated:** 2020-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00738894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00738894, "GORE® Septal Occluder Device for Patent Foramen Ovale (PFO) Closure in Stroke Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00738894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*